Description: After the COVID-19 epidemic, more and more pharma emerging markets and countries strongly demand localized manufacturing. “Innovative Vaccine Technology Transfer and Local Manufacturing” becomes one of the main streams of local industry growth. To meet the above demand, Tofflon works with his strategic partners and SME team to offer” Affordable Innovation Solutions” from technology transfer, WHO PQ Compliance Quality System Establishment to local manufacturing through innovative “Machinery + Modular Engineering + Value-Added Service for Bio-Technology Transfer” Solution. In the end, all our jointly developed “Affordable Innovation” will bring values to the ultimate benefit of our people.
This webinar will discuss three pivotal areas essential for successful technology transfer and local manufacturing: building a WHO-PQ compliant QA System, adhering to best practices in vaccine technology transfer, and utilizing innovative modular Drug Substance (DS) and Drug Product (DP) facilities for vaccine local manufacturing.







